VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- May 15, 2007 -- Tekmira Pharmaceuticals Corporation (“Tekmira”) (TSX: TKM) reported today in its First Quarter 2007 operating results that its spin-off from Inex Pharmaceuticals Corporation (“INEX”) was successfully completed May 1, 2007 and the Company remains on track to complete all its 2007 drug development milestones.
